Search Results - "Onafuye, Hannah"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity by Pieper, Sebastian, Onafuye, Hannah, Mulac, Dennis, Cinatl, Jindrich, Wass, Mark N, Michaelis, Martin, Langer, Klaus

    Published in Beilstein journal of nanotechnology (29-10-2019)
    “…Background: Nanoparticles are under investigation as carrier systems for anticancer drugs. The expression of efflux transporters such as the ATP-binding…”
    Get full text
    Journal Article
  2. 2

    Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells by Onafuye, Hannah, Pieper, Sebastian, Mulac, Dennis, Cinatl, Jr, Jindrich, Wass, Mark N, Langer, Klaus, Michaelis, Martin

    “…Resistance to systemic drug therapy is a major reason for the failure of anticancer therapies. Here, we tested doxorubicin-loaded human serum albumin (HSA)…”
    Get full text
    Journal Article
  3. 3

    Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy by Ward, Jane L., Wu, Yanqi, Harflett, Claudia, Onafuye, Hannah, Corol, Delia, Lomax, Charlotte, Macalpine, William J., Cinatl, Jindrich, Wass, Mark N., Michaelis, Martin, Beale, Michael H.

    Published in Scientific reports (15-04-2020)
    “…Willow (Salix spp.) is well known as a source of medicinal compounds, the most famous being salicin, the progenitor of aspirin. Here we describe the isolation,…”
    Get full text
    Journal Article
  4. 4

    Investigation of Drug-Adapted Cancer Cell Lines as Pre-Clinical Models of Acquired Resistance by Onafuye, Hannah

    Published 01-01-2019
    “…Drug-adapted cancer cell lines have been successfully used to identify clinically relevant drug resistance mechanisms. This project focused on the further…”
    Get full text
    Dissertation